Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics |
Funding Information: | Funder Grant number Cancer Research UK Supplier No: 138573 RCS REF 08-0843 SUBCONTR Cancer Research UK Supplier No: 138573 C6003/A7367 Cancer Research UK Supplier No: 138573 C7852/A19772 Cancer Research UK Supplier No: 138573 C6003/A3830 MRC (Medical Research Council) NOT GIVEN Leeds Hospitals Charity 1T01-A321 Leeds Teaching Hospitals Charitable Foundation 4616 |
Depositing User: | Symplectic Publications |
Date Deposited: | 17 Jul 2023 08:14 |
Last Modified: | 17 Jul 2023 08:14 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.annonc.2022.07.475 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:201428 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online